Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-053753

Watanabe Todd sold 4,375 shares at $26.12 ($114,261)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Watanabe Todd

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-03 Sale : show line 1 in the form 10b5-1 −4,375 $26.12 $114,261 717,203 D
Open-market sales · 4,375 sh · avg $26.12 · $114,261
Loading xslF345X06/wk-form4_1785980527.xml…